BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23102779)

  • 1. Antitumor effects of exogenous ganglioside GM3 on bladder cancer in an orthotopic cancer model.
    Wang H; Isaji T; Satoh M; Li D; Arai Y; Gu J
    Urology; 2013 Jan; 81(1):210.e11-5. PubMed ID: 23102779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer.
    Black PC; Brown GA; Dinney CP; Kassouf W; Inamoto T; Arora A; Gallagher D; Munsell MF; Bar-Eli M; McConkey DJ; Adam L
    J Urol; 2011 Feb; 185(2):693-700. PubMed ID: 21168861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic viral therapy by bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model.
    Wang H; Satoh M; Abe H; Sunamura M; Moriya T; Ishidoya S; Saito S; Hamada H; Arai Y
    Urology; 2006 Sep; 68(3):674-81. PubMed ID: 16979729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
    Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
    BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
    Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
    Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth.
    Jeong KC; Kim KT; Seo HH; Shin SP; Ahn KO; Ji MJ; Park WS; Kim IH; Lee SJ; Seo HK
    J Urol; 2014 Feb; 191(2):510-8. PubMed ID: 23872029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits epidermal growth factor receptor signaling pathway activation and induces apoptosis in bladder cancer cells in vitro and in vivo.
    Chang L; Xiao W; Yang Y; Li H; Xia D; Yu G; Guo X; Guan W; Hu Z; Xu H; Zhuang Q; Ye Z
    Urol Oncol; 2014 Jan; 32(1):36.e11-8. PubMed ID: 23948182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
    Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
    BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells.
    Satoh M; Ito A; Nojiri H; Handa K; Numahata K; Ohyama C; Saito S; Hoshi S; Hakomori SI
    Int J Oncol; 2001 Oct; 19(4):723-31. PubMed ID: 11562747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.
    Mugabe C; Matsui Y; So AI; Gleave ME; Baker JH; Minchinton AI; Manisali I; Liggins R; Brooks DE; Burt HM
    Clin Cancer Res; 2011 May; 17(9):2788-98. PubMed ID: 21357680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
    Nagasawa J; Mizokami A; Koshida K; Yoshida S; Naito K; Namiki M
    Int J Urol; 2006 May; 13(5):587-92. PubMed ID: 16771730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.
    Watanabe R; Ohyama C; Aoki H; Takahashi T; Satoh M; Saito S; Hoshi S; Ishii A; Saito M; Arai Y
    Cancer Res; 2002 Jul; 62(13):3850-4. PubMed ID: 12097299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
    Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Su Fu'ning Lotion's Inhibitory Effects on Bladder Cancer Cells In Vitro and In Vivo by Intravesical Instillation.
    Ren L; Yang X; Zhao L; Zhang H; Wang J
    Integr Cancer Ther; 2016 Mar; 15(1):80-6. PubMed ID: 26315609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
    Azuma H; Takahara S; Horie S; Muto S; Otsuki Y; Katsuoka Y
    J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
    Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
    J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
    Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG
    Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer.
    Blietz CE; Thode B; Hauses M; Pries R; Meyer AJ; Doehn C; Jocham D; Kausch I
    In Vivo; 2009; 23(1):13-9. PubMed ID: 19368119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.